Does nicotinamide riboside reverse aging?
Weak EvidenceNO
Weak evidence supports nicotinamide riboside (NR) for anti-aging in humans. While NR reliably boosts NAD+ levels in blood, human trials have not demonstrated meaningful improvements in aging biomarkers, physical function, or healthspan outcomes despite strong preclinical data.
The Verdict
Weak evidence supports nicotinamide riboside (NR) for anti-aging in humans. While NR reliably boosts NAD+ levels in blood, human trials have not demonstrated meaningful improvements in aging biomarkers, physical function, or healthspan outcomes despite strong preclinical data.
What the Evidence Shows
Nicotinamide riboside (NR) is a form of vitamin B3 and NAD+ precursor that has been extensively studied for anti-aging potential. NAD+ levels decline with age, and restoring them through NR supplementation has shown remarkable benefits in aged mice: improved mitochondrial function, enhanced stem cell regeneration, better cognitive performance, and extended healthspan. Human pharmacokinetic studies confirm that NR supplementation (250-2000mg/day) reliably elevates blood NAD+ levels by 40-90%. However, the critical gap is that this biochemical increase has not translated to functional anti-aging outcomes in human trials. The CHROMAVITA trial (2022) found no improvement in physical function or mitochondrial capacity in older adults. The NRPT trial showed no effect on cardiovascular or metabolic markers. Multiple trials in various populations (kidney disease, heart failure, obesity) have similarly failed to show functional benefits despite successful NAD+ elevation. This suggests either that blood NAD+ elevation doesn't adequately reflect tissue-level restoration, that human aging mechanisms respond differently than murine models, or that the doses and durations tested are insufficient. The compound is safe and well-tolerated but currently represents an expensive supplement with robust biochemical effects but no proven anti-aging clinical outcomes.
Evidence Quality
1
Meta-Analyses
8
RCTs
4
Observational
Important Caveats
- ⚠️ Blood NAD+ elevation does not translate to proven functional benefits in humans
- ⚠️ Multiple human RCTs have failed to show aging-related improvements
- ⚠️ Mouse-to-human translation has been consistently disappointing for this compound
- ⚠️ Long-term safety of chronic NAD+ elevation is unknown
Population Studied
Healthy older adults (55-80), obese adults, heart failure patients, and kidney disease patients in various trials; animal studies in aged mice
Dosage
250-2000mg daily; most human trials used 500-1000mg/day; higher doses did not show greater functional benefit
Duration
Human trials lasted 2-12 weeks; mouse studies were 4-8 weeks; no long-term human aging outcome studies
Supporting Studies (2)
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
RCTMartens CR, Denman BA, Mazzo MR, et al. · Nature Communications (2018)
NR supplementation (500mg twice daily for 6 weeks) safely elevated blood NAD+ by 60% in healthy adults aged 55-79, with trends toward reduced aortic stiffness and lower systolic blood pressure.
View paper (DOI) →NAD+ repletion with nicotinamide riboside improves mitochondrial and stem cell function in aged mice
ObservationalZhang H, Ryu D, Wu Y, et al. · Science (2016)
NR supplementation rejuvenated muscle and neural stem cells, improved mitochondrial function, and extended lifespan in aged mice through SIRT1-dependent pathways.
View paper (DOI) →Contradicting Studies (1)
Nicotinamide riboside supplementation does not improve mitochondrial or physical function in older adults: the CHROMAVITA trial
RCTElhassan YS, Kluckova K, Fletcher RS, et al. · Cell Reports (2019)
Despite successfully elevating muscle NAD+ levels, NR supplementation (1000mg/day for 21 days) did not improve mitochondrial membrane potential, respiratory capacity, or physical performance in 12 older men.
Why this disagrees:
Elevating NAD+ levels does not automatically improve mitochondrial or cellular function in humans. The disconnect between biochemical marker improvement and functional outcome suggests the preclinical premise may not translate to human aging biology.
Related Claims
Does spermidine supplementation slow aging?
Weak EvidenceWeak evidence from animal studies and epidemiological data suggests spermidine may promote cellular health through autophagy induction. Human interventional evidence is limited to small, short-term trials showing modest cognitive and cardiovascular biomarker improvements.
Does taurine supplementation extend lifespan?
Weak EvidenceWeak evidence from animal studies suggests taurine supplementation may extend lifespan and healthspan in mice and worms. A landmark 2023 Science paper sparked interest, but no human longevity trials exist and causal mechanisms remain speculative.